298 related articles for article (PubMed ID: 31260733)
1. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles guided drug delivery and imaging in gastric cancer.
Nagaraju GP; Srivani G; Dariya B; Chalikonda G; Farran B; Behera SK; Alam A; Kamal MA
Semin Cancer Biol; 2021 Feb; 69():69-76. PubMed ID: 31954835
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles for Colorectal Cancer Targeted Drug Delivery and MR Imaging: Current Situation and Perspectives.
Dong Z; Cui MY; Peng Z; Li Y; Wang X; Fang Z; Jiang M; Xu L; Luo Y; Li ZP; Feng ST
Curr Cancer Drug Targets; 2016; 16(6):536-50. PubMed ID: 26632434
[TBL] [Abstract][Full Text] [Related]
4. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
5. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
Ho BN; Pfeffer CM; Singh ATK
Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
[TBL] [Abstract][Full Text] [Related]
6. Recent achievements in colorectal cancer diagnostic and therapy by the use of nanoparticles.
Bartoş A; Bartoş D; Szabo B; Breazu C; Opincariu I; Mironiuc A; Iancu C
Drug Metab Rev; 2016; 48(1):27-46. PubMed ID: 26828283
[TBL] [Abstract][Full Text] [Related]
7. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
[TBL] [Abstract][Full Text] [Related]
8. Targeting the extracellular signature of metastatic colorectal cancers.
Marchiò S; Arap W; Pasqualini R
Expert Opin Ther Targets; 2009 Mar; 13(3):363-79. PubMed ID: 19236157
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview.
Kulwal V; Baxi K; Sawarkar SP; Bhatt LK
Crit Rev Ther Drug Carrier Syst; 2020; 37(1):65-104. PubMed ID: 32450014
[TBL] [Abstract][Full Text] [Related]
10. Triumph against cancer: invading colorectal cancer with nanotechnology.
Vinchhi P; Patel MM
Expert Opin Drug Deliv; 2021 Sep; 18(9):1169-1192. PubMed ID: 33567909
[TBL] [Abstract][Full Text] [Related]
11. Engineered nanoparticles for drug delivery in cancer therapy.
Sun T; Zhang YS; Pang B; Hyun DC; Yang M; Xia Y
Angew Chem Int Ed Engl; 2014 Nov; 53(46):12320-64. PubMed ID: 25294565
[TBL] [Abstract][Full Text] [Related]
12. Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review.
Shazleen Ibrahim I; Starlin Chellathurai M; Mahmood S; Hakim Azmi A; Harun N; Ulul Ilmie Ahmad Nazri M; Muzamir Mahat M; Mohamed Sofian Z
Int J Pharm; 2024 Feb; 651():123735. PubMed ID: 38142874
[TBL] [Abstract][Full Text] [Related]
13. Smart Drug-Delivery Systems for Cancer Nanotherapy.
Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
[TBL] [Abstract][Full Text] [Related]
14. Drug delivery approaches for breast cancer.
Singh SK; Singh S; Lillard JW; Singh R
Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic nanoparticles for drug delivery in cancer.
Cho K; Wang X; Nie S; Chen ZG; Shin DM
Clin Cancer Res; 2008 Mar; 14(5):1310-6. PubMed ID: 18316549
[TBL] [Abstract][Full Text] [Related]
16. Integrating natural compounds and nanoparticle-based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy.
Manzari-Tavakoli A; Babajani A; Tavakoli MM; Safaeinejad F; Jafari A
Cancer Med; 2024 Mar; 13(5):e7010. PubMed ID: 38491817
[TBL] [Abstract][Full Text] [Related]
17. Implications of nanotechnology for the treatment of cancer: Recent advances.
Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
[TBL] [Abstract][Full Text] [Related]
18. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.
Grifantini R; Taranta M; Gherardini L; Naldi I; Parri M; Grandi A; Giannetti A; Tombelli S; Lucarini G; Ricotti L; Campagnoli S; De Camilli E; Pelosi G; Baldini F; Menciassi A; Viale G; Pileri P; Cinti C
J Control Release; 2018 Jun; 280():76-86. PubMed ID: 29733876
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin based nanoparticles for smart drug delivery in colorectal cancer.
Marabada D; Li J; Wei S; Huang Q; Wang Z
Chem Biol Drug Des; 2023 Dec; 102(6):1618-1631. PubMed ID: 37705133
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles in oncology: the new theragnostic molecules.
Allegra A; Penna G; Alonci A; Rizzo V; Russo S; Musolino C
Anticancer Agents Med Chem; 2011 Sep; 11(7):669-86. PubMed ID: 21787275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
